Skip to content

Drug interactions

Pimavanserin + Quizartinib

Severity: Major

Pimavanserin and Quizartinib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs prolong the QT interval, and quizartinib carries a boxed warning for QT prolongation and torsades de pointes. Combining them increases the risk of serious ventricular arrhythmia.

What this interaction means in plain words

Pimavanserin and Quizartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Pimavanserin belongs to Central Nervous System; Quizartinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QT prolongation.

What to do

Avoid if possible; if unavoidable, monitor ECGs frequently and keep potassium and magnesium normal. Reduce or hold quizartinib if QTc rises significantly.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pimavanserin and Quizartinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Pimavanserin with Quizartinib?

MediHelp rates the interaction as major. Pimavanserin and Quizartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs prolong the QT interval, and quizartinib carries a boxed warning for QT prolongation and torsades de pointes. Combining them increases the risk of serious ventricular arrhythmia.

How serious is the interaction between Pimavanserin and Quizartinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; if unavoidable, monitor ECGs frequently and keep potassium and magnesium normal. Reduce or hold quizartinib if QTc rises significantly.

What other medicines interact with Pimavanserin?

MediHelp also lists interactions of Pimavanserin with, for example, Lefamulin, Pimozide, Vandetanib. The full list is on the Pimavanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in